| Vorinostat | IC50 | 10000.0 [1] |
| Vorinostat | Ki | 49.0 [1], 65.0 [2], 2000.0 [3] |
| Trichostatin A | IC50 | 38.1 [1] |
| Trichostatin A | Ki | 800.0 [1] |
| Panobinostat | IC50 | 887.8 [1], 888.0 [2], 2680.0 [3] |
| Panobinostat | Ki | 1.2 [1], 830.0 [2], 3200.0 [3] |
| Tubastatin A | IC50 | 621.0 [1], 4310.0 [2], 30000.0 [3] |
| Romidepsin | IC50 | 10000.0 [1], 50000.0 [2] |
| Romidepsin | Ki | 1100.0 [1] |
| Tubacin | IC50 | 4310.0 [1], 30000.0 [2] |
| Tubacin | Ki | 509.3 [1], 6300.0 [2] |
| Belinostat | Ki | 24.0 [1], 250.0 [2] |
| Dacinostat | IC50 | 8.24 [1] |
| Dacinostat | Ki | 9000.0 [1] |
| Ricolinostat | IC50 | 10000.0 [1] |
| CID 53344908 | IC50 | 19.4 [1], 20.0 [2], 23.24 [3] |
| Scriptaid | IC50 | 700.0 [1] |
| Scriptaid | Ki | 8000.0 [1] |
| Largazole | IC50 | 8330.0 [1], 10000.0 [2] |
| Quisinostat | Ki | 3.8 [1], 5.3 [2] |
| Givinostat | Ki | 390.0 [1] |
| (E)-N-Hydroxy-3-[2-(2-phenylethyl)-1-(2-pyrrolidin-1-ylethyl)benzimidazol-5-yl]prop-2-enamide | Ki | 19.0 [1], 19.2 [2] |
| (1r,2r,3r)-2-[4-(5-Fluoranylpyrimidin-2-Yl)phenyl]-N-Oxidanyl-3-Phenyl-Cyclopropane-1-Carboxamide | IC50 | 190.0 [1], 200.0 [2] |
| N-[[4-[(E)-3-(Hydroxyamino)-3-oxoprop-1-enyl]cyclohexyl]methyl]-4,4-dimethyl-2-oxo-1,3-dihydroquinoline-6-carboxamide | IC50 | 5.2 [1], 91.0 [2] |
| N-[[4-[3-(Hydroxyamino)-3-oxopropyl]cyclohexyl]methyl]-4,4-dimethyl-2-oxo-1,3-dihydroquinoline-6-carboxamide | IC50 | 50.0 [1], 57.0 [2] |
| Valproic acid | IC50 | 2000000.0 [1] |
| Butyric acid | IC50 | 2000000.0 [1] |
| 4-Phenylbutyric acid | IC50 | 2000000.0 [1] |
| Entinostat | IC50 | 100000.0 [1] |
| N-Hydroxybenzamide | IC50 | 33330.0 [1] |
| Pracinostat | Ki | 24.0 [1] |
| Cudc-101 | IC50 | 67.2 [1] |
| Fimepinostat | IC50 | 554.0 [1] |
| 1-(3,4-Dihydroxyphenyl)-2-[(4-hydroxy-6-methylpyrimidin-2-YL)thio]ethanone | IC50 | 100000.0 [1] |
| Thailandepsin A | IC50 | 50000.0 [1] |
| Nexturastat A | IC50 | 6720.0 [1] |
| Azumamide E | IC50 | 28000.0 [1] |
| N-Hydroxy-4-phenylbutanamide | IC50 | 430000.0 [1] |
| N-Hydroxy-2,2-diphenylacetamide | IC50 | 510.0 [1] |
| CID 11427204 | IC50 | 82.0 [1] |
| 2-[(4-Methyl-6-oxo-1,6-dihydropyrimidin-2-yl)sulfanyl]-N-(2-phenylethyl)acetamide | IC50 | 100000.0 [1] |
| 2-[(4-Hydroxy-6-methylpyrimidin-2-yl)sulfanyl]-1-(4-methoxyphenyl)ethanone | IC50 | 100000.0 [1] |
| 4-[2-[2-Hydroxyethyl(Phenyl)amino]-2-Oxidanylidene-Ethyl]-~{n}-Oxidanyl-Benzamide | IC50 | 10000.0 [1] |
| N-Hydroxy-2-(4-(naphthalen-2-ylsulfonyl)piperazin-1-yl)pyrimidine-5-carboxamide | IC50 | 28.0 [1] |
| HDAC inhibitor | IC50 | 2344.0 [1] |
| N-(4-{[(4-Hydroxy-6-methylpyrimidin-2-yl)sulfanyl]acetyl}phenyl)acetamide | IC50 | 74100.0 [1] |
| (S)-Benzyl (6-acetamido-1-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxohexan-2-yl)carbamate | IC50 | 1024.0 [1] |
| 6-Methyl-2-{[2-oxo-2-(thiophen-2-yl)ethyl]sulfanyl}-3,4-dihydropyrimidin-4-one | IC50 | 100000.0 [1] |
| N-Hydroxy-5-[[6-oxo-4-(4-phenylphenyl)-1H-pyrimidin-2-yl]sulfanyl]pentanamide | IC50 | 50000.0 [1] |
| (E)-N-Hydroxy-3-[4-(4-methoxyphenyl)phenyl]prop-2-enamide | IC50 | 39300.0 [1] |
| Pimelic Diphenylamide 106 | IC50 | 100000.0 [1] |
| N-Hydroxybutanamide | IC50 | 2000000.0 [1] |
| N-[1-[[3-Azido-5-(azidomethyl)phenyl]methyl]pyrazol-4-yl]-N'-hydroxyoctanediamide | IC50 | 704.0 [1] |
| Thailandepsin B | IC50 | 50000.0 [1] |
| 3-N-Hydroxy-1-N-(2-phenylethyl)benzene-1,3-dicarboxamide | IC50 | 33000.0 [1] |
| N-Hydroxy-2-propylpentanamide | IC50 | 91000.0 [1] |
| Benzamide, N-(((6-(hydroxyamino)-6-oxohexyl)amino)carbonyl)- | Ki | 55.0 [1] |
| N-Hydroxy-4-[(quinolin-8-ylamino)methyl]benzamide | IC50 | 1530.0 [1] |
| 6-Methyl-2-phenacylsulfanyl-1H-pyrimidin-4-one | IC50 | 100000.0 [1] |
| 2-(4-Chlorophenacylthio)-4-hydroxy-6-methylpyrimidine | IC50 | 100000.0 [1] |
| Pandacostat | Ki | 1400.0 [1] |
| 5-[[4-Ethoxy-3-(1-methyl-7-oxo-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-5-yl)phenyl]methyl]-N-hydroxythiophene-2-carboxamide | IC50 | 10000.0 [1] |
| N-Hydroxy-7-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]octanamide | IC50 | 8500.0 [1] |
| (E)-N-Hydroxy-3-[4-(4-hydroxyphenyl)phenyl]prop-2-enamide | IC50 | 8920.0 [1] |
| 2-(4-Methoxybenzyloxy)-N8-hydroxy-N1-phenyloctanediamide | IC50 | 247.0 [1] |
| (2E,4E)-N-[6-(Hydroxyamino)-6-oxohexyl]-3-methyl-5-phenyl-2,4-pentadienamide | IC50 | 4.2 [1] |
| (2E,4E)-N-Hydroxy-5-[4-(4-methoxyphenyl)phenyl]penta-2,4-dienamide | IC50 | 100000.0 [1] |
| 3-(4-Aroyl-1-methyl-1H-pyrrol-2-yl)-N-hydroxy-2-propenamide | Ki | 10000.0 [1] |
| 1-[5-[3-[4-(1,3,4-Oxadiazole-2-yl)phenoxymethyl]-1,2,4-oxadiazole-5-yl]-2-thienyl]trifluoroethanone | IC50 | 20.0 [1] |
| (E)-3-[1-[3-(Dimethylamino)-2,2-dimethylpropyl]-2-(2-phenylethyl)benzimidazol-5-yl]-N-hydroxyprop-2-enamide | Ki | 21.0 [1] |
| (3S,6S,9S,13S)-9-Methyl-13-(2-methylpropyl)-3-(naphthalen-1-ylmethyl)-6-(6-oxooctyl)-1,4,7,10-tetrazacyclotridecane-2,5,8,11-tetrone | IC50 | 10000.0 [1] |
| 5-[4-[[3-Azido-5-(azidomethyl)benzoyl]amino]phenyl]-N-[7-(hydroxyamino)-7-oxoheptyl]-1,2-oxazole-3-carboxamide | IC50 | 37.8 [1] |
| (E)-N-Hydroxy-3-[4-(trifluoromethyl)phenyl]prop-2-enamide | IC50 | 100000.0 [1] |
| 2-((3-Phenethoxyphenyl)Amino)Benzamide | IC50 | 30000.0 [1] |
| (1r,2r,3r)-2-[4-(1,3-Oxazol-5-Yl)phenyl]-N-Oxidanyl-3-Phenyl-Cyclopropane-1-Carboxamide | IC50 | 40.0 [1] |
| (E)-N-Hydroxy-3-[2-(2-phenylethyl)-1-(2-piperidin-1-ylethyl)benzimidazol-5-yl]prop-2-enamide | Ki | 24.0 [1] |
| (2R)-2-[(1-Hydroxy-6-sulfanylidenepyridine-2-carbonyl)amino]propanoic acid | IC50 | 58000.0 [1] |
| (2R)-2-[(1-Hydroxy-6-sulfanylidenepyridine-2-carbonyl)amino]-2-phenylacetic acid | IC50 | 34000.0 [1] |
| (7R)-N-Hydroxy-7-[(4-pyridin-3-ylpyrimidin-2-yl)amino]-5,6,7,8-tetrahydronaphthalene-2-carboxamide | IC50 | 35000.0 [1] |
| N-Hydroxy-2-[[5-(3-nitrophenyl)furan-2-yl]methyl]-3,4-dihydro-1H-isoquinoline-7-carboxamide | IC50 | 65800.0 [1] |
| N-{4-[2-(4,6-Dimethyl-pyrimidin-2-ylsulfanyl)-acetyl]-phenyl}-acetamide | IC50 | 100000.0 [1] |
| 2-(4-(4-(4-Fluorophenyl)-1-hydroxybut-3-en-2-yl)piperazin-1-yl)-N-hydroxypyrimidine-5-carboxamide | IC50 | 40.7 [1] |
| N-[7-(Hydroxyamino)-7-oxoheptyl]-2-methoxyquinoline-6-carboxamide | IC50 | 34.0 [1] |
| N-[7-(Hydroxyamino)-7-oxoheptyl]-2-oxo-1H-quinoline-6-carboxamide | IC50 | 46.0 [1] |
| N-[7-(Hydroxyamino)-7-oxoheptyl]-1,4,4-trimethyl-2-oxo-3H-quinoline-6-carboxamide | IC50 | 120.0 [1] |
| N-[7-(Hydroxyamino)-7-oxoheptyl]-1-methyl-2-oxoquinoline-6-carboxamide | IC50 | 41.0 [1] |
| N'-Hydroxy-N-(2-oxo-1H-quinolin-6-yl)octanediamide | IC50 | 58.0 [1] |
| 4-[(1,1-Dioxo-2,3-dihydrothieno[3,2-b]indol-4-yl)methyl]-N-hydroxybenzamide | IC50 | 200.0 [1] |
| N-Hydroxy-5-(1-phenylpyrazol-3-yl)pentanamide | IC50 | 55800.0 [1] |
| 5-[1-[(4-Anilinophenyl)methyl]pyrazol-3-yl]-N-hydroxypentanamide | IC50 | 18300.0 [1] |
| N-Hydroxy-5-[1-[(4-phenylphenyl)methyl]pyrazol-3-yl]pentanamide | IC50 | 47200.0 [1] |
| N-[6-[(E)-3-(Hydroxyamino)-3-oxoprop-1-enyl]pyridin-3-yl]-2,3-diphenylpropanamide | IC50 | 10600.0 [1] |
| 3-(4-(Di(1H-indol-3-yl)methyl)phenyl)-N-hydroxyacrylamide | IC50 | 3300.0 [1] |
| N-Hydroxy-7,7-bis(1H-indol-3-yl)heptanamide | IC50 | 640.0 [1] |
| N-Hydroxy-7,7-bis(7-methoxy-1H-indol-3-yl)heptanamide | IC50 | 340.0 [1] |
| (1R,5S)-N-[2-Amino-5-(4-fluorophenyl)phenyl]-8-oxabicyclo[3.2.1]octane-3-carboxamide | IC50 | 33330.0 [1] |
| (3S,6Z,9R,12R,16S)-6-Ethylidene-3,12-di(propan-2-yl)-16-[(E)-4-sulfanylbut-1-enyl]-9-(sulfanylmethyl)-1-oxa-4,7,10,13-tetrazacyclohexadecane-2,5,8,11,14-pentone | IC50 | 10000.0 [1] |
| (4Z,7S,10S,14R)-4-Ethylidene-7,14-di(propan-2-yl)-10-[(E)-4-sulfanylbut-1-enyl]-9-oxa-16-thia-3,6,13,18-tetrazabicyclo[13.2.1]octadeca-1(17),15(18)-diene-2,5,8,12-tetrone | IC50 | 10000.0 [1] |
| S-[(E)-4-[(4Z,7S,10S,14R)-4-Ethylidene-2,5,8,12-tetraoxo-7,14-di(propan-2-yl)-9-oxa-16-thia-3,6,13,18-tetrazabicyclo[13.2.1]octadeca-1(17),15(18)-dien-10-yl]but-3-enyl] octanethioate | IC50 | 10000.0 [1] |
| Hdac6-IN-1 | IC50 | 10000.0 [1] |